To investigate the effect of ginseng on damaged brain activity, we evaluated the cerebral metabolic rate of glucose (CMRglc) as a functional index in post-ischaemic rats and compared the results with those obtained after the administration of a ginseng extract. CMRglc was measured using high resolut
Differential effects of teriparatide on regional bone formation using 18F-fluoride positron emission tomography
β Scribed by Michelle L Frost; Musib Siddique; Glen M Blake; Amelia EB Moore; Paul J Schleyer; Joel T Dunn; Edward J Somer; Paul K Marsden; Richard Eastell; Ignac Fogelman
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2011
- Tongue
- English
- Weight
- 185 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0884-0431
- DOI
- 10.1002/jbmr.305
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Teriparatide increases skeletal mass, bone turnover markers, and bone strength, but local effects on bone tissue may vary between skeletal sites. We used positron emission tomography (PET) to study ^18^Fβfluoride plasma clearance (K~i~) at the spine and standardized uptake values (SUVs) at the spine, pelvis, total hip, and femoral shaft in 18 postmenopausal women with osteoporosis. Subjects underwent a 1βhour dynamic scan of the lumbar spine and a 10βminute static scan of the pelvis and femurs at baseline and after 6 months of treatment with 20βΒ΅g/day teriparatide. Blood samples were taken to derive the arterial input function and lumbar spine K~i~ values evaluated using a threeβcompartment model. SUVs were calculated for the spine, pelvis, total hip, and femoral shaft. After 6 months treatment with teriparatide, spine K~i~ values increased by 24% (p=β.0003), while other model parameters were unchanged except for the fraction of tracer going to bone mineral (k~3~/[k~2~β+βk~3~]), which increased by 23% (p=β.0006). In contrast to K~i~, spine SUVs increased by only 3% (p=β.84). The discrepancy between changes in K~i~ and SUVs was explained by a 20% decrease in ^18^F^β^ plasma concentration. SUVs increased by 37% at the femoral shaft (p=β.0019), 20% at the total hip (p=β.032), and 11% at the pelvis (p=β.070). Changes in bone turnover markers and BMD were consistent with previous trials. We conclude that the changes in bone formation rate during teriparatide treatment as measured by ^18^F^β^ PET differ at different skeletal sites, with larger increases in cortical bone than at trabecular sites. Β© 2011 American Society for Bone and Mineral Research.
π SIMILAR VOLUMES
We have investigated the ability of dopamine to compete with the binding of the high affinity dopamine D 2 receptor positron emission tomography (PET) radioligand, 18 F-fallypride. In vitro dissociation of 18 F-fallypride with dopamine in rat striatal homogenates exhibited a dissociation rate, k off